ArticleChemical science2026
pH-activatable brominated pentamethine cyanine dyes for imaging-guided photodynamic immunotherapy of tumors.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photodynamic therapy (PDT) has emerged as a minimally invasive antitumor strategy, yet conventional photosensitizers often suffer from off-target phototoxicity under physiological conditions. This study presents a novel pH-activatable brominated pentamethine cyanine dye (C-CyBr) as a smart photosensitizer for imaging-guided photodynamic therapy (PDT). A hydroxylated indole moiety was rationally introduced as the pH-sensitive switch. Under neutral physiological pH (7.4), the dye exists in a closed-ring non-fluorescent and photoinert state with negligible reactive oxygen species (ROS) generation and fluorescence emission. In contrast, once exposed to the acidic tumor microenvironment (pH ≤ 6.5, the critical activation threshold), the hydroxyl group undergoes rapid protonation, which restores the conjugated π-electron system, activates fluorescence imaging signals and simultaneously unlocks the photosensitizing activity. C-CyBr was further used to prepar nanoparticles (OCBr), which exhibit excellent tumor accumulation
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.